Title : Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction.

Pub. Date : 2016 Mar

PMID : 26873495






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the large, randomized, double-blind, PARADIGM-HF trial, sacubitril/valsartan reduced the incidence of death from cardiovascular causes or first hospitalization for worsening heart failure (composite primary endpoint) significantly more than the angiotensin converting enzyme (ACE) inhibitor enalapril. Valsartan angiotensin I converting enzyme Homo sapiens